Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.
The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.
MorphoSys shares are currently gaining nearly 37%.

Source: xStation
Meta Platforms shares surge amid Jefferies 'Buy' recommendation 📈
US Open: Rebound attempt on Wall Street 📈Meta Platforms surges 3.5%
Stock of the Week: TSMC, the heart of the global AI revolution (January 22, 2026)
Intel Q4 2025: Quarterly Results Will Show If the Strategy Works 📊